Table 3.

Participants’ attitudes towards pharmacogenomics (PGx) applications by profession.

Question/Statement	Response N = 131 (%) Ordinal Logistic Regression Output
	Unlikely	Neutral	Likely	O.R	S.E	p-Value
How likely is it that PGx testing will help to decrease the number of adverse drug reactions?	13 (10%)	13 (10%)	105 (80%)	0.4	0.2	0.06
How likely is it that PGx testing will help to decrease the cost of developing new drugs?	32 (24%)	18 (14%)	81 (62%)	1.9	0.7	0.06
How likely is it that PGx testing will reduce the time it takes to find the optimal dose for patients on warfarin?	6 (5%)	16 (12%)	109 (83%)	3.0	1.4	0.02
How likely is it that PGx testing will help reduce ADR’s due to warfarin?	4 (3%)	20 (15%)	107 (82%)	0.6	0.3	0.3